These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 4102332)

  • 1. [Analysis of chemotherapy with 2d line drugs in patients with chronic fibro-cavernous pulmonary tuberculosis].
    Warm S
    Gruzlica; 1971; 39(3):201-7. PubMed ID: 4102332
    [No Abstract]   [Full Text] [Related]  

  • 2. [Diagnostic importance of the quantitative determination of the extent of bacteria excretion during the chemotherapy process in chronic destructive pulmonary tuberculosis].
    Khomenko AG; Kozulitsyna TI; Kaminskaia AA; Andrusskaia MK; Khlopovskiĭ SG
    Probl Tuberk; 1981 Jun; (6):17-22. PubMed ID: 7024984
    [No Abstract]   [Full Text] [Related]  

  • 3. [Fate of patients with pulmonary tuberculosis and secondary drug resistance to the major drugs].
    Kost A
    Gruzlica; 1969 Nov; 37(11):997-1002. PubMed ID: 5368630
    [No Abstract]   [Full Text] [Related]  

  • 4. [L-forms of Mycobacterium tuberculosis during chemotherapy of patients with chronic destructive pulmonary tuberculosis].
    Karachunskiĭ MA; Dorozhkova IR; Kaminskaia AA; Abdullaeva ET
    Probl Tuberk; 1983 Jul; (7):38-43. PubMed ID: 6415651
    [No Abstract]   [Full Text] [Related]  

  • 5. [Intermittent chemotherapy of chronic forms of pulmonary tuberculosis].
    Ershov AI; Tikhonov VA; Zheltukhina NI; Chesmochakova IV
    Probl Tuberk; 1976 Feb; (21):31-4. PubMed ID: 817283
    [No Abstract]   [Full Text] [Related]  

  • 6. [Prolonged chemotherapy in dispensary patients with fibro-cavernous pulmonary tuberculosis].
    Khudushina TA
    Probl Tuberk; 1967; 45(6):46-51. PubMed ID: 5604889
    [No Abstract]   [Full Text] [Related]  

  • 7. [Comparative characteristics of the use of rifadin and ethambutol in the complex treatment of patients with fibro-cavernous pulmonary tuberculosis].
    Tarasova EF; Sagalovich VIa
    Probl Tuberk; 1974; (12):26-30. PubMed ID: 4445131
    [No Abstract]   [Full Text] [Related]  

  • 8. [Results of treatment of chronic pulmonary tuberculosis Mycobacterium in the sputum].
    Petrović B; Radović R; Petrović O; Arsenijević N; Jevdjić P; Jordanov S
    Tuberkuloza; 1967; 19(5):658-60. PubMed ID: 4971786
    [No Abstract]   [Full Text] [Related]  

  • 9. [Late results of an experimental pilot for short-term tuberculosis chemotherapy in cases that are positive by microscopy].
    Anastasatu C; Bercea O; Corlan E
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1984; 33(4):321-34. PubMed ID: 6097991
    [No Abstract]   [Full Text] [Related]  

  • 10. Chemotherapy of chronic destructive tuberculosis of the lungs and some disputable drugs.
    Schmelev NA
    Scand J Respir Dis Suppl; 1968; 65():147-50. PubMed ID: 4978458
    [No Abstract]   [Full Text] [Related]  

  • 11. [Retrospective analysis of cure of tuberculosis].
    Maszczyk Z; Zajaczkowska J
    Gruzlica; 1969 Sep; 37(9):843-52. PubMed ID: 5349675
    [No Abstract]   [Full Text] [Related]  

  • 12. [Primary resistance to major antitubercular drugs in patients with recently discovered pulmonary tuberculosis in the yea.s 1961-1969].
    Zduńczyk-Pawelek H; Antosiewicz A; Blitek-Golc D
    Gruzlica; 1971 Feb; 39(2):89-93. PubMed ID: 5551351
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effect of the inhalation of tuberculostatic aerosols on the dynamics of bacterial excretion in pulmonary tuberculosis patients].
    Protsiuk RG
    Probl Tuberk; 1983 May; (5):38-42. PubMed ID: 6408637
    [No Abstract]   [Full Text] [Related]  

  • 14. A microscopic method for the evaluation of the bacillary output in sputum of tuberculous patients under chemotherapy.
    Bercea O; Bogdănescu V; Marcian S; Ceicu A
    Scand J Respir Dis; 1969; 50(2):89-100. PubMed ID: 4898946
    [No Abstract]   [Full Text] [Related]  

  • 15. [Value of the bacteriological study of the associated bacterial flora of the sputum of patients with chronic pulmonary tuberculosis].
    Boccitto G; Salvati F; De Ritis G
    Policlinico Prat; 1970 Apr; 77(15):477-89. PubMed ID: 4987995
    [No Abstract]   [Full Text] [Related]  

  • 16. Surgical treatment of chronic infectious pulmonary tuberculosis without antituberculous chemotherapeutic cover.
    Mlekodaj S
    Pol Med J; 1971; 10(5):1173-8. PubMed ID: 5002489
    [No Abstract]   [Full Text] [Related]  

  • 17. [A controlled trial of 6-month and 12-month regimens after negative conversion of sputum in the original treatment of pulmonary tuberculosis. Report of the 21st series of controlled trials of chemotherapy. Cooperative Study Unit of Chemotherapy of Tuberculosis of National Sanatoria in Japan (CSUCTNS)].
    Kekkaku; 1984 Feb; 59(2):81-9. PubMed ID: 6379258
    [No Abstract]   [Full Text] [Related]  

  • 18. [Criteria of inactivity in pulmonary tuberculosis after correct chemotherapy].
    Bek E; Bukalska Z; Stachlewska S; Zachara A
    Gruzlica; 1968 Oct; 36(10):897-907. PubMed ID: 5710094
    [No Abstract]   [Full Text] [Related]  

  • 19. [Dynamics of the excretion of the bacilli in patients with destructive pulmonary tuberculosis under the effect of long-term tuberculostatic therapy].
    Fisher EF; Velichko SA; Sharaburova OE; Strelis AK
    Lab Delo; 1973; 6():340-2. PubMed ID: 4129386
    [No Abstract]   [Full Text] [Related]  

  • 20. Sputum smear status at two months and subsequent treatment outcome in new patients with smear-positive pulmonary tuberculosis.
    Salaniponi FM; Christensen JJ; Gausi F; Kwanjana JJ; Harries AD
    Int J Tuberc Lung Dis; 1999 Nov; 3(11):1047-8. PubMed ID: 10587328
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.